Article info
PDFCases that changed my practice
Visual loss when treating giant cell arteritis
Citation
Visual loss when treating giant cell arteritis
Publication history
- First published November 21, 2006.
Online issue publication
November 21, 2006
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry
Other content recommended for you
- An elastic Van Gieson stain is unnecessary for the histological diagnosis of giant cell temporal arteritis
- Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications
- Giant cell arteritis
- 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
- Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
- Visual loss in giant cell arteritis 3 weeks after steroid initiation
- Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
- Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis
- Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases
- New headaches with normal inflammatory markers: an early atypical presentation of giant cell arteritis